Search results for: 'ngs in ca'
- Related search terms
- NGS China
- ngs markets
- NGS market
- NGS Informatics Market Forecast to 2027
- NGS tertiary analysis
-
13 Jan 2023  |  Global  |  Market Research
Global Life Science Instrumentation and Research Tool Growth Opportunities
Automation and Robotization to Ensure Industrywide Streamlining and Increase Future Growth Potential
New technological advances in life science instrumentation and research tools include the enhancement of next-generation sequencing (NGS) technology, digital PCR, and a wide range of informatics, robotics, and automated solutions. These improve workflow, facilitate and automate tasks, and make better use of workspaces in every area of industry. ...
$4,950.00
Special Price $3,712.50 save 25 %
-
22 Apr 2024  |  Global  |  Market Research
Global Molecular Diagnostics Market, Forecast to 2029
Molecular Diagnostics Unleash Growth Opportunities, Steering Innovation Personalized Medicine
The global molecular diagnostic market will experience significant growth due to a broad range of factors, such as increased demand from the COVID-19 pandemic, an increasing number of cancer cases, and the swift evolution of technological capabilities. Technological advancements, such as polymerase chain reaction (PCR), digital PCR, and next-gen...
$4,950.00
Special Price $3,712.50 save 25 %
-
19 Feb 2025  |  Global  |  Market Research
Top 10 Strategic Imperatives in the Life Sciences Industry, 2025
Key Challenges, Trends, and Changes Transforming the Life Sciences Industry
Owing to constant developments and challenges in the life sciences industry, stakeholders must continue to be adaptable, innovative, and competitive to thrive. Industry leaders must reconsider their strategic positions annually by understanding the main forces behind the transformation, including potential, challenges, and drivers. This analysis e...
$2,450.00
Special Price $2,205.00 save 10 %
-
03 Jan 2024  |  Global  |  Market Research
Top 5 Growth Opportunities for the Pharmaceutical Industry, 2024
Tech-enabled Partnerships Propelling Drug Discovery and Development in Precision Oncology, Rare Diseases, and Obesity
In 2024, the life science (LS) industry s focus on precision health will intensify. LS companies will augment their omics-based research capabilities and increasingly deploy AI and bioinformatics to discover personalized therapies. Partnerships between pharmaceutical companies and technology vendors will multiply, to support innovation in drug disc...
$2,450.00
Special Price $1,837.50 save 25 %
-
29 Aug 2025  |  Global  |  Market Research
Oncology Biomarker Diagnostics, Global, 2024–2030
Regulatory Approvals, Companion Diagnostic Partnerships, and Precision Medicine are Driving Transformational Growth in the Industry, Fueled by Advances in Genomic Profiling and AI Integration
This research service offers a comprehensive analysis of the global oncology biomarker diagnostics market, which has transformed with the convergence of clinical demand, advances in technology, and strategic collaborations/partnerships coupled with precision medicine initiatives. It categorizes the market by technology (omics, immunoassays, bioinfo...
$4,950.00 -
09 Jul 2025  |  Global  |  Market Outlook
Global Clinical Diagnostics Outlook, 2025
Driven by Novel Biomarkers, Digital Services, and Automation, Industry is Accelerating Precision, Efficiency, and Early Disease Detection in Molecular Diagnostics and Point-of-care Testing (POCT)
The global clinical diagnostics market is poised for strong growth as stakeholders shift focus toward high-growth segments such as precision medicine, decentralized diagnostics, software-driven solutions, and product expansion. Companies continue to adopt LIMS and other digital platforms while emerging opportunities in the POCT sector further drive...
$4,950.00
Special Price $4,455.00 save 10 %
-
19 Jan 2024  |  Europe  |  Market Research
European Non-invasive Prenatal Testing Market, Forecast to 2028
Driving Progress in Screening Techniques Amplifies Accessibility and Adoption of NIPT, Cultivating a Broader Patient Engagement in Europe
The European non-invasive prenatal testing (NIPT) market will experience significant growth thanks to technological advancement, increasing awareness among expectant parents, and the rising incidence of chromosomal abnormalities in fetuses. The market has experienced a surge in demand due to its products non-invasive nature compared to traditional...
$4,950.00
Special Price $3,712.50 save 25 %
-
28 Jun 2024  |  Global  |  Market Research
Life Science Instrumentation and Research Tools Driving Transformational Growth through Automation Global, 2023 2029
A Steady Increase in Laboratory Budgets in Academia is Driving Innovation
This study analyzes the life science instrumentation and research tools industry, covering the chemicals, consumables, instruments, reagents, suppliers, and IT solutions used in research laboratories. The global market for life science instrumentation and research tools is projected to experience steady growth from 2023 to 2029, achieving significa...
$4,950.00
Special Price $3,712.50 save 25 %
-
22 Oct 2025  |  Global  |  Technology Research
Beyond CRISPR: Recent Technology Advances in Rewriting DNA
Emerging Tools Reshaping the Future of Gene Editing
This study highlights advancements such as prime editing, base editing, bridge RNA, SeekRNA, and gene writing platforms, as it examines the emerging field of next-generation gene editing technologies beyond CRISPR/Cas systems. These tools are revolutionary for therapeutic development, precision medicine, and functional genomics because they provide...
$4,950.00 -
13 Dec 2022  |  Global  |  Technology Research
Companion Diagnostics (CDx): Technology Innovation and Growth Opportunities
The Transition to Precision Medicine is Propelling the Adoption of CDx Platforms.
The concept of companion diagnostics (CDx) was developed when researchers realized that even potent drugs only had an efficacy between 25% and 60%, the lowest being in oncology. Therefore, a clinical pharmacogenetic assay became important to distinguish patients more likely to respond to a drug or at a lesser risk of associated adverse pathophysiol...
$4,950.00
Special Price $3,712.50 save 25 %